Norelgestromin
|  | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| MedlinePlus | a602006 | 
| Routes of administration | Transdermal patch | 
| Legal status | 
 | 
| Identifiers | |
| CAS Number | 53016-31-2  | 
| ATC code | G03AA13 (WHO) (only combinations with estrogens) | 
| PubChem | CID 62930 | 
| DrugBank | DB06713  | 
| ChemSpider | 56648  | 
| UNII | R0TAY3X631  | 
| KEGG | D05205  | 
| ChEBI | CHEBI:111762  | 
| ChEMBL | CHEMBL1200807  | 
| Synonyms | 17-Deacetylnorgestimate, levonorgestrel 3-oxime | 
| Chemical data | |
| Formula | C21H29NO2 | 
| Molar mass | 327.461 g/mol | 
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Norelgestromin (INN, USAN, BAN), or norelgestromine, is a steroidal progestin used in the contraceptive patch called Evra or Ortho Evra, where it is combined with the estrogen ethinyl estradiol.[1][2] It is one of the active metabolites of norgestimate.[3]
References
- ↑ Drugs.com: Norelgestromin/Ethinyl Estradiol Patch
- ↑ Crosignani, P. G.; Nappi, C.; Ronsini, S.; Bruni, V.; Marelli, S.; Sonnino, D.; Study Group, I. E. C. (2009). "Satisfaction and compliance in hormonal contraception: The result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy". BMC Women's Health 9: 18. doi:10.1186/1472-6874-9-18. PMC 2714834. PMID 19566925.
- ↑ Annette M. Doherty (2003). Annual Reports in Medicinal Chemistry. Academic Press. pp. 362–. ISBN 978-0-12-040538-1.
| 
 | ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.